Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Share-based Compensation (2018 - 2025)

Chemours (CC) has 8 years of Share-based Compensation data on record, last reported at $4.0 million in Q4 2025.

  • For Q4 2025, Share-based Compensation rose 33.33% year-over-year to $4.0 million; the TTM value through Dec 2025 reached $21.0 million, up 50.0%, while the annual FY2025 figure was $21.0 million, 40.0% up from the prior year.
  • Share-based Compensation reached $4.0 million in Q4 2025 per CC's latest filing, down from $5.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $12.0 million in Q1 2021 and bottomed at $1.0 million in Q1 2024.
  • Average Share-based Compensation over 5 years is $5.6 million, with a median of $5.0 million recorded in 2023.
  • Peak YoY movement for Share-based Compensation: skyrocketed 700.0% in 2021, then plummeted 75.0% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $10.0 million in 2021, then plummeted by 70.0% to $3.0 million in 2022, then skyrocketed by 66.67% to $5.0 million in 2023, then plummeted by 40.0% to $3.0 million in 2024, then surged by 33.33% to $4.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $4.0 million in Q4 2025, $5.0 million in Q3 2025, and $7.0 million in Q2 2025.